The combined action of hyaluronic acid and fibronectin stimulates neutrophil migration.
Previous investigations have demonstrated that the chemotactic response of polymorphonuclear leukocytes (PMN) was stimulated by hyaluronic acid (HA) when serum was present. The aim of the present investigation was to identify the serum factor necessary for the stimulation of PMN chemotaxis by HA. By means of gel filtration, the m.w. of the serum component was shown to be greater than 350,000. Immunoprecipitation of serum with anti-fibronectin, but not with anti-IgM and anti-alpha 2-macroglobulin, inhibited the stimulation of PMN chemotaxis by HA. Preincubation of PMN with HA (10 to 500 micrograms/L) and isolated fibronectin (0.1 to 100 mg/L) significantly stimulated the chemotactic response of PMN. Also, random migration of PMN was significantly increased by preincubation of the cells with HA (10 to 500 micrograms/L) and isolated fibronectin (50 to 200 mg/L). Additionally, PMN preincubated with HA (10 to 50 micrograms/L) and with fibronectin (10 to 50 mg/L) added afterwards, and PMN preincubated with fibronectin (10 mg/L) and with HA (5 to 10 micrograms/L) added after the preincubation, showed a significant stimulation of the chemotactic response. PMN preincubated with serum and chondroitin sulfate, or with fibrinogen and HA, demonstrated no stimulation of the chemotactic response. The present investigation suggests that the combined action of HA and fibronectin, which probably takes place at the cellular membrane, is a major mechanism in the HA-mediated stimulation of PMN migration.
D001790:Blood Physiological Phenomena; D002465:Cell Movement / Q000187:drug effects; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D002809:Chondroitin Sulfates / Q000494:pharmacology; D002850:Chromatography, Gel; D005340:Fibrinogen / Q000494:pharmacology; D005353:Fibronectins / Q000276:immunology / Q000302:isolation & purification / Q000502:physiology*; D006801:Humans; D006820:Hyaluronic Acid / Q000494:pharmacology*; D007106:Immune Sera / Q000494:pharmacology; D046911:Macromolecular Substances; D008970:Molecular Weight; D009504:Neutrophils / Q000502:physiology*
D005353:Fibronectins; D007106:Immune Sera; D046911:Macromolecular Substances; D005340:Fibrinogen; D006820:Hyaluronic Acid; D002809:Chondroitin Sulfates